JP Morgan Chase
MIRM icon

JP Morgan Chase’s Mirum Pharmaceuticals MIRM Stock Holding History

JP Morgan Chase’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,600
Closed -$283K – 7700
2023
Q4 		$283K Buy
+9,600
New +$291K ﹤0.01% 5140

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase's MIRM Position: Q2 2026 in Review

JP Morgan Chase reduced its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, selling an estimated $970K and leaving 81,001 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2777.

JP Morgan Chase first reported a position in MIRM in Q3 2019 and has held it in 28 quarters since. The position peaked at $24.4M in Q2 2025. 226 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • JP Morgan Chase held 81,001 shares of Mirum Pharmaceuticals worth $10.2M as of Q2 2026.
  • JP Morgan Chase sold 9,663 Mirum Pharmaceuticals shares in Q2 2026, an estimated $970K.
  • Mirum Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2777 holding.
  • JP Morgan Chase first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • JP Morgan Chase's Mirum Pharmaceuticals position peaked at $24.4M in Q2 2025.
  • 226 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.